[
  {
    "question": "What is Dysfibrinogenemia?",
    "options": [
      "A deficiency in fibrinogen production",
      "A qualitative defect in fibrinogen function",
      "An increased level of fibrinogen in the blood",
      "A complete absence of fibrinogen"
    ],
    "answer": "A qualitative defect in fibrinogen function",
    "explanation": "Dysfibrinogenemia refers to an abnormal fibrinogen molecule that is produced in normal or near-normal amounts but functions abnormally in clot formation."
  },
  {
    "question": "Which gene is most commonly mutated in congenital Dysfibrinogenemia?",
    "options": [
      "FGA",
      "FGB",
      "FGG",
      "All of the above"
    ],
    "answer": "All of the above",
    "explanation": "Congenital Dysfibrinogenemia is often associated with mutations in one of the three fibrinogen genes: FGA, FGB, or FGG."
  },
  {
    "question": "Which laboratory test often shows prolonged results in Dysfibrinogenemia?",
    "options": [
      "Prothrombin time (PT)",
      "Activated partial thromboplastin time (aPTT)",
      "Thrombin time (TT)",
      "Bleeding time"
    ],
    "answer": "Thrombin time (TT)",
    "explanation": "Thrombin time is particularly prolonged in Dysfibrinogenemia due to impaired fibrin polymerization."
  },
  {
    "question": "Which of the following is the most frequent clinical presentation of Dysfibrinogenemia?",
    "options": [
      "Severe bleeding",
      "No symptoms (asymptomatic)",
      "Thrombosis",
      "Recurrent miscarriages"
    ],
    "answer": "No symptoms (asymptomatic)",
    "explanation": "Many individuals with Dysfibrinogenemia remain asymptomatic, though some present with bleeding, thrombosis, or pregnancy complications."
  },
  {
    "question": "Which diagnostic ratio is useful in Dysfibrinogenemia diagnosis?",
    "options": [
      "Fibrinogen activity-to-antigen ratio",
      "Prothrombin-to-antithrombin ratio",
      "Platelet count-to-MCV ratio",
      "PT-to-aPTT ratio"
    ],
    "answer": "Fibrinogen activity-to-antigen ratio",
    "explanation": "A low activity-to-antigen ratio suggests qualitative abnormalities in fibrinogen, characteristic of Dysfibrinogenemia."
  },
  {
    "question": "What is the inheritance pattern of congenital Dysfibrinogenemia?",
    "options": [
      "Autosomal dominant",
      "Autosomal recessive",
      "X-linked",
      "Mitochondrial"
    ],
    "answer": "Autosomal dominant",
    "explanation": "Most congenital Dysfibrinogenemia cases are inherited in an autosomal dominant pattern."
  },
  {
    "question": "Which acquired condition can cause Dysfibrinogenemia?",
    "options": [
      "Cirrhosis",
      "Diabetes mellitus",
      "Iron deficiency anemia",
      "Vitamin C deficiency"
    ],
    "answer": "Cirrhosis",
    "explanation": "Acquired Dysfibrinogenemia is most often seen in liver disease, particularly cirrhosis, due to abnormal fibrinogen synthesis."
  },
  {
    "question": "Which symptom is more commonly associated with Dysfibrinogenemia than with Afibrinogenemia?",
    "options": [
      "Mild bleeding",
      "Excessive thrombosis",
      "Delayed wound healing",
      "Nosebleeds"
    ],
    "answer": "Excessive thrombosis",
    "explanation": "Unlike afibrinogenemia, dysfibrinogenemia can paradoxically predispose patients to thrombosis due to abnormal fibrin clot formation."
  },
  {
    "question": "Which of the following is a possible complication of Dysfibrinogenemia during pregnancy?",
    "options": [
      "Pre-eclampsia",
      "Recurrent miscarriages",
      "Gestational diabetes",
      "Placenta previa"
    ],
    "answer": "Recurrent miscarriages",
    "explanation": "Women with Dysfibrinogenemia may experience pregnancy complications such as recurrent miscarriages due to abnormal clotting."
  },
  {
    "question": "Which treatment may be required in severe bleeding episodes in Dysfibrinogenemia?",
    "options": [
      "Fibrinogen concentrate",
      "Heparin",
      "Vitamin K",
      "Warfarin"
    ],
    "answer": "Fibrinogen concentrate",
    "explanation": "Replacement therapy with fibrinogen concentrate or cryoprecipitate is used in severe bleeding episodes."
  },
  {
    "question": "Which is preferred for long-term monitoring of Dysfibrinogenemia patients?",
    "options": [
      "Fibrinogen antigen levels",
      "Fibrinogen activity levels",
      "D-dimer testing",
      "Thrombin generation assay"
    ],
    "answer": "Fibrinogen activity levels",
    "explanation": "Fibrinogen activity is key to understanding functional clotting capacity, unlike antigen levels that only measure quantity."
  },
  {
    "question": "Which assay confirms Dysfibrinogenemia?",
    "options": [
      "Functional fibrinogen assay",
      "Genetic sequencing of fibrinogen genes",
      "Both A and B",
      "None"
    ],
    "answer": "Both A and B",
    "explanation": "Diagnosis requires both functional clotting assays and often genetic confirmation for congenital cases."
  },
  {
    "question": "What type of fibrin clot abnormality is seen in Dysfibrinogenemia?",
    "options": [
      "Delayed polymerization",
      "Increased fibrinolysis",
      "Cross-linking defects",
      "All of the above"
    ],
    "answer": "All of the above",
    "explanation": "Dysfibrinogenemia clots may exhibit delayed polymerization, abnormal cross-linking, or increased lysis."
  },
  {
    "question": "Which condition is most likely to coexist with acquired Dysfibrinogenemia?",
    "options": [
      "Chronic kidney disease",
      "Liver cirrhosis",
      "Diabetes mellitus",
      "Leukemia"
    ],
    "answer": "Liver cirrhosis",
    "explanation": "Abnormal fibrinogen molecules in acquired dysfibrinogenemia are most often due to liver dysfunction."
  },
  {
    "question": "In Dysfibrinogenemia, which laboratory pattern is typical?",
    "options": [
      "Normal antigen, reduced activity",
      "Reduced antigen, reduced activity",
      "Normal antigen, normal activity",
      "Increased antigen, reduced activity"
    ],
    "answer": "Normal antigen, reduced activity",
    "explanation": "The hallmark pattern is normal fibrinogen antigen with reduced functional activity, reflecting qualitative defects."
  },
  {
    "question": "What is the estimated prevalence of Dysfibrinogenemia?",
    "options": [
      "1 in 1,000",
      "1 in 10,000",
      "1 in 1,000,000",
      "Unknown, rare disorder"
    ],
    "answer": "Unknown, rare disorder",
    "explanation": "Dysfibrinogenemia is very rare, and its true prevalence remains uncertain."
  },
  {
    "question": "Which form of Dysfibrinogenemia is more common?",
    "options": [
      "Congenital",
      "Acquired"
    ],
    "answer": "Acquired",
    "explanation": "Acquired Dysfibrinogenemia due to liver disease is more common than congenital genetic forms."
  },
  {
    "question": "Which factor increases thrombosis risk in Dysfibrinogenemia patients?",
    "options": [
      "Prolonged PT",
      "Abnormal fibrin structure",
      "Decreased fibrinogen antigen",
      "Increased platelet count"
    ],
    "answer": "Abnormal fibrin structure",
    "explanation": "Defective fibrin formation may paradoxically predispose to thrombosis by producing unstable clots prone to embolization."
  },
  {
    "question": "What is the primary clinical management strategy for asymptomatic patients?",
    "options": [
      "No treatment, observation",
      "Daily anticoagulants",
      "Prophylactic fibrinogen replacement",
      "Liver transplantation"
    ],
    "answer": "No treatment, observation",
    "explanation": "Asymptomatic Dysfibrinogenemia usually requires no intervention, with treatment reserved for clinical events."
  },
  {
    "question": "Which laboratory finding helps differentiate Dysfibrinogenemia from Hypofibrinogenemia?",
    "options": [
      "Normal fibrinogen antigen in Dysfibrinogenemia",
      "Low fibrinogen antigen in Hypofibrinogenemia",
      "Both A and B",
      "Neither"
    ],
    "answer": "Both A and B",
    "explanation": "Hypofibrinogenemia shows decreased antigen and activity, while Dysfibrinogenemia shows normal antigen but low activity."
  }
]
